| 1 |
Computed tomography perfusion as a predictor of gastric cancer grades |
2024 |
| 2 |
Contrast enhanced digital mammography as a predictor of breast cancer in patient with pathological nipple discharge |
2024 |
| 3 |
Diagnostic efficacy of Ovarian-Adnexal Reporting and Data System (ORADS) in Evaluation of Ovarian Lesions |
2024 |
| 4 |
Quantitative and qualitative Assessment of Superficial lymph nodes by B mode ultrasound, colour Doppler and sonoElastography |
2024 |
| 5 |
Quantitative and Qualitative Assessment of Superficial Lymph Nodes by B-mode Ultrasound, Color Doppler and Sono elastography |
2024 |
| 6 |
Role of Irreversible Electroporation in Solid Abdominal Tumors Management |
2024 |
| 7 |
Visceral and Subcutaneous Fat, Muscle Mass, and Liver Volume as Non-invasive Predictors of the Progress of Non-alcoholic Fatty Liver Disease |
2023 |
| 8 |
Contrast-Enhanced Digital Mammography Versus Digital Mammography in The Discrimination between Benign and Malignant Breast Lesions |
2022 |
| 9 |
Fine‑needle aspiration cytology versus core needle lymph node biopsy in axillary staging of breast cancer |
2022 |
| 10 |
Contrast-enhanced digital mammography versus digital mammography in the discrimination between benign and malignant breast lesions |
2022 |
